Cargando…
The use of platelet‐rich plasma in treatment of olfactory dysfunction: A pilot study
BACKGROUND: Olfactory dysfunction is a prevalent problem with a significant impact on quality of life and increased mortality. Limited effective therapies exist. Platelet‐rich plasma (PRP) is an autologous biologic product with anti‐inflammatory and neuroprotective effects. This novel pilot study ev...
Autores principales: | Yan, Carol H., Mundy, David C., Patel, Zara M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178450/ https://www.ncbi.nlm.nih.gov/pubmed/32337347 http://dx.doi.org/10.1002/lio2.357 |
Ejemplares similares
-
Platelet-rich plasma injection in the olfactory clefts of COVID-19 patients with long-term olfactory dysfunction
por: Lechien, Jerome R., et al.
Publicado: (2022) -
Olfactory implant: Demand for a future treatment option in patients with olfactory dysfunction
por: Besser, Gerold, et al.
Publicado: (2018) -
Impact of COVID‐19 versus chronic rhinosinusitis/rhinitis associated olfactory dysfunction on health utility and quality of life
por: Luong, Thanh, et al.
Publicado: (2022) -
Olfactory dysfunction in passive vs active smoking
por: Çengel Kurnaz, Senem, et al.
Publicado: (2021) -
Evaluation of predictive value of olfactory dysfunction, as a screening tool for COVID‐19
por: Romero‐Gameros, Carlos Alfonso, et al.
Publicado: (2020)